8
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

      Submit here before September 30, 2024

      About Blood Purification: 3.0 Impact Factor I 5.6 CiteScore I 0.83 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Effect of High Haematocrit on the Efficiency of High-Flux Dialysis Therapies

      research-article
      , ,
      Nephron Clinical Practice
      S. Karger AG
      Blood flow, Clearance, Haemodialysis, high flux

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: There is a concern that high haematocrit (Hct) levels will reduce the efficiency of dialysis treatments, particularly in post-dilution haemodiafiltration (HDF) where there is the potential for intense haemoconcentration within the dialyser. Methods: We measured serial Hct and performed serial clearance measurements for urea, phosphate, β<sub>2</sub>-microglobulin and myoglobin in 12 patients with Hct >35% on high-flux haemodialysis (HFHD) or HDF. We assessed whether changes in the intra-dialyser Hct influenced solute clearance and whether there were differences between the two modalities. Results: Hct rose significantly in all treatments studied. Convective and total solute clearances were higher in the HDF group when compared to the HFHD group. Phosphate clearance in HFHD fell towards the end of dialysis when the Hct was highest but no differences were detected for the other solutes. Conclusion: Despite marked haemoconcentration, the impact on solute clearance across the range of molecular size studied is small. These findings are reassuring in the current era of widespread erythropoietin use.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Convective mass transfer in hemodialysis.

          Convective mass transfer in hemodialysis is associated with ultrafiltration (UF). In the absence of diffusion as in hemofiltration, the convective clearance is equal to S.QF where S is the apparent solute sieving coefficient and QF the UF flow rate, but the convective contribution significantly decreases when diffusion is present. A rigorous calculation of the combined diffusion-convection mass transfer for partially rejected solutes is very complex. In this paper we review various models of mass fluxes found in the literature. Since all these models express the mass flux through the membrane as a linear function of blood and dialysate concentrations with different coefficients, we present a general expression for the hemodiafiltration clearance combining diffusion and convection which can be adapted to each model of mass flux. A surprising result is that the convective contribution to the clearance is, in the limit of dominant ultrafiltration, independent of the solute sieving coefficient, in contrast to the model of Villaroel et al. This is due to the effect of increased solute concentration at the membrane which compensates exactly for the effect of the sieving coefficient. This effect is overlooked in the Villaroel et al. model which assumes well mixed blood and dialysate compartments. Comparison with in vitro clearance measurements for urea, creatinin, vitamin B12, and myoglobin (16,000 daltons) supports this observation even when diffusion dominates as in the case of clinical conditions for hemodiafiltration. An empirical correlation for the overall clearance valid for all solutes and blood flows between 200 and 500 ml/min is found to be K = KD + 0.43 QF + 8.3 x 10(-3) Q2F when clearances and QF are in ml/min.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Simultaneous convective and diffusive mass transfers in a hemodialyser.

            The mass transfer in a hemodialyser in the presence of combined dialysis and ultrafiltration has been calculated by integration of mass fluxes across the boundary layers in blood and dialysate phase taking into account the partial rejection of solute as well as changes in local blood flow and ultrafiltration flux along the membrane. Clearances of creatinin, vitamin B12, and myoglobin have been calculated as a function of blood and ultrafiltrate flow rate and were found to be in good agreement with in vitro measurements. The data suggest the following empirical correlation for the hemodiafiltration clearance.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Effects of Hematocrit and Blood Flow Distribution on Solute Clearance in Hollow-Fiber Hemodialyzers

                Bookmark

                Author and article information

                Journal
                NEC
                Nephron Clin Pract
                10.1159/issn.1660-2110
                Nephron Clinical Practice
                S. Karger AG
                1660-2110
                2008
                November 2008
                10 September 2008
                : 110
                : 2
                : c86-c92
                Affiliations
                Renal Unit, Lister Hospital, Stevenage, UK
                Article
                153778 Nephron Clin Pract 2008;110:c86
                10.1159/000153778
                18781079
                c8da9fc4-226f-4722-8432-fcab7ea75ffc
                © 2008 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 30 October 2007
                : 04 March 2008
                Page count
                Figures: 5, Tables: 4, References: 9, Pages: 1
                Categories
                Original Paper

                Cardiovascular Medicine,Nephrology
                Blood flow,Clearance,Haemodialysis, high flux
                Cardiovascular Medicine, Nephrology
                Blood flow, Clearance, Haemodialysis, high flux

                Comments

                Comment on this article